Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
The American Journal of Surgical Pathology|September 10, 2019
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)Susanna Leskela, Ignacio Romero, Eva Cristobal, et al.Gynecologic Oncology|April 29, 2025
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trialAndrés Poveda, Stéphanie Lheureux, Nicoletta Colombo, et al.International Journal of Molecular Sciences|July 14, 2023
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)David Pizarro, Ignacio Romero, Belén Pérez-Mies, et al.Annals of Surgical Oncology|January 23, 2015
Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)Jordi Rubió-Casadevall, Javier Martinez-Trufero, Xabier Garcia-Albeniz, et al.The American Journal of Surgical Pathology|April 16, 2020
Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and ConsequencesSusanna Leskela, Ignacio Romero, Eva Cristobal, et al.The American Journal of Surgical Pathology|May 9, 2020
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular ClassificationSusanna Leskela, Ignacio Romero, Juan M Rosa-Rosa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas studyXavier García-Del-Muro, Antonio López-Pousa, Joan Maurel, et al.The Lancet. Oncology|July 30, 2017
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trialEric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, et al.Clinical Sarcoma Research|July 1, 2016
Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 studyJoan Maurel, Antonio López-Pousa, Silvia Calabuig, et al.Cancer|November 13, 2019
Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft modelsJanice M Santiago-O'Farrill, S John Weroha, Xiaonan Hou, et al.Pageof 6